- Home
- THTX vs STIM Comparison
THTX vs STIM Comparison
Compare THTX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- STIM
- Stock Information
- Founded
- THTX 1993
- STIM 2003
- Country
- THTX Canada
- STIM United States
- Employees
- THTX N/A
- STIM 201
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- THTX Health Care
- STIM Health Care
- Exchange
- THTX Nasdaq
- STIM Nasdaq
- Market Cap
- THTX 93.3M
- STIM 192.0M
- IPO Year
- THTX N/A
- STIM 2018
- Fundamental
- Price
- THTX $1.48
- STIM $3.52
- Analyst Decision
- THTX Hold
- STIM Buy
- Analyst Count
- THTX 1
- STIM 4
- Target Price
- THTX N/A
- STIM $4.67
- AVG Volume (30 Days)
- THTX 108.7K
- STIM 1.3M
- Earning Date
- THTX 02-19-2025
- STIM 03-04-2025
- Dividend Yield
- THTX N/A
- STIM N/A
- EPS Growth
- THTX N/A
- STIM N/A
- EPS
- THTX N/A
- STIM N/A
- Revenue
- THTX $84,316,000.00
- STIM $72,711,000.00
- Revenue This Year
- THTX $5.78
- STIM $1.97
- Revenue Next Year
- THTX $2.47
- STIM $7.96
- P/E Ratio
- THTX N/A
- STIM N/A
- Revenue Growth
- THTX 5.75
- STIM 5.03
- 52 Week Low
- THTX $1.08
- STIM $0.52
- 52 Week High
- THTX $2.18
- STIM $5.07
- Technical
- Relative Strength Index (RSI)
- THTX 36.81
- STIM 72.45
- Support Level
- THTX $1.42
- STIM $2.34
- Resistance Level
- THTX $1.76
- STIM $3.69
- Average True Range (ATR)
- THTX 0.09
- STIM 0.38
- MACD
- THTX -0.05
- STIM 0.08
- Stochastic Oscillator
- THTX 17.63
- STIM 71.68
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.